About 60% of people diagnosed with pancreatic cancer don't qualify for surgery because their disease is too advanced. For these patients, treatment typically begins with chemotherapy, in the hope that the tumor will shrink enough to be surgically removed, which offers the best chance of long-term survival. A new clinical trial at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) is testing a custom imaging tool designed to measure much earlier whether that chemotherapy is working, so treatment can change quickly if it is not.